These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9935065)

  • 1. Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique.
    Ito H; Halldin C; Farde L
    J Nucl Med; 1999 Jan; 40(1):102-9. PubMed ID: 9935065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
    Ito H; Okubo Y; Halldin C; Farde L
    Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.
    Farde L; Ito H; Swahn CG; Pike VW; Halldin C
    J Nucl Med; 1998 Nov; 39(11):1965-71. PubMed ID: 9829590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
    Andrée B; Halldin C; Pike VW; Gunn RN; Olsson H; Farde L
    J Nucl Med; 2002 Mar; 43(3):292-303. PubMed ID: 11884487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.
    Passchier J; van Waarde A; Pieterman RM; Elsinga PH; Pruim J; Hendrikse HN; Willemsen AT; Vaalburg W
    J Nucl Med; 2000 Nov; 41(11):1830-5. PubMed ID: 11079490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.
    Farde L; Ginovart N; Ito H; Lundkvist C; Pike VW; McCarron JA; Halldin C
    Psychopharmacology (Berl); 1997 Sep; 133(2):196-202. PubMed ID: 9342787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
    Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
    Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.
    Tauscher J; Verhoeff NP; Christensen BK; Hussey D; Meyer JH; Kecojevic A; Javanmard M; Kasper S; Kapur S
    Neuropsychopharmacology; 2001 May; 24(5):522-30. PubMed ID: 11282252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.
    Parsey RV; Slifstein M; Hwang DR; Abi-Dargham A; Simpson N; Mawlawi O; Guo NN; Van Heertum R; Mann JJ; Laruelle M
    J Cereb Blood Flow Metab; 2000 Jul; 20(7):1111-33. PubMed ID: 10908045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
    Hirvonen J; Karlsson H; Kajander J; Lepola A; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):465-76. PubMed ID: 17971260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907.
    Ito H; Nyberg S; Halldin C; Lundkvist C; Farde L
    J Nucl Med; 1998 Jan; 39(1):208-14. PubMed ID: 9443763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
    Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L
    Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
    Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
    Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workshop on 5-HT1A receptor imaging--modelling of [carbonyl-11C]WAY-100635 in the human brain. 6 May 1999, PET Centre, San Raffaele, Milan, Italy.
    Eur J Nucl Med; 1999 Aug; 26(8):948-50. PubMed ID: 10515717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.